HIF1A and cancer: Importantly, high HIF-1α levels and, to some extent, high Gal3 expression are associated with a poorer survival of human cancer patients, in particular in association with mutant KRAS, which emphasizes the need for suitable potent inhibitors (Figure S4C–F).